Article

Article detail, metadata, authors, and available full-text links.

Paper reader

Loading paper...

article · 2019

A phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy with LHRH agonist or antagonist versus anti-androgen therapy with apalutamide in patients with biochemical progression after radical prostatectomy

0 citationsDOI: https://doi.org/10.1093/annonc/mdz248.057Open accessPDF reported by metadata
A phase II randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy with LHRH agonist or antagonist versus anti-androgen therapy with apalutamide in patients with biochemical progression after radical prostatectomy